Last Updated: May 10, 2026

Details for Patent: 8,323,683


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,323,683 protect, and when does it expire?

Patent 8,323,683 protects NICORETTE and is included in two NDAs.

This patent has twenty-two patent family members in seventeen countries.

Summary for Patent: 8,323,683
Title:Flavoring of drug-containing chewing gums
Abstract:A chewing gum comprising at least one active pharmaceutical ingredient (API) with a core onto which is applied at least one inner polymer film coating and thereafter onto which is applied at least one outer hard coating. A preferred API is nicotine. Flavoring agents may be incorporated in the core, in the at least one inner polymer film coating and/or in the at least one outer hard coating. The gums formed exhibit a long lasting effect of flavoring agent(s) and result in the domination of flavoring agents in the coating(s) over flavoring agent(s) in the core, thereby (a) avoiding problems of chemical or pharmaceutical incompatibility between an API in the core and flavoring agent(s) in the coating(s) and (b) achieving an increased control of the release of the API and of non-active excipients.
Inventor(s):Seema Mody, Gregory Koll
Assignee: McNeil AB
Application Number:US11/131,561
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

United States Patent 8,323,683: Scope of Claims and US Nicotine Chewing Gum Landscape

US Patent 8,323,683 claims a chewing gum architecture engineered to control flavor perception during mastication by using a core with nicotine and pH regulation, an inner polymer coating with a high level of a “second” flavor system, and an outer hard coating that drives the predominant flavor outcome. The patent’s practical scope is less about nicotine formulation chemistry and more about two-layer coating design that creates a specific temporal flavor release profile in nicotine gum.


What is the protected chewing gum architecture in Claim 1?

Claim 1 is a three-part system:

1) Core: nicotine + pH regulation + “first” flavor system + sweetener

The core comprises:

  • Chewing gum base
  • Nicotine in any form
  • A first flavoring agent
  • A first sweetener
  • At least one pH regulating agent

Claim scope notes

  • “Nicotine in any form” is broad. It reads on nicotine salts, freebase nicotine, and other nicotine forms used in oral nicotine products, subject to formulation feasibility.
  • The “first” flavoring agent and “first” sweetener are not limited to any specific chemical identity in Claim 1.

2) Inner polymer coating: specific polymer family + second flavor + second sweetener

An inner polymer coating is applied to the core. It must include:

  • A polymer selected from:
    • Hydroxypropylmethyl cellulose (HPMC)
    • Hydroxypropyl cellulose (HPC)
    • mixtures thereof
  • A second flavoring agent present in an amount of:
    • 30% to 50% by weight of the inner polymer coating
  • A second sweetener
  • Inner polymer coating amount:
    • about 0.5% to about 20% by weight of the core

Claim scope notes

  • The polymer restriction is a hard boundary: the inner coating must use HPMC/HPC or mixtures, not other film-formers.
  • The “30% to 50% by weight” requirement is a defining limitation. It is not “effective amount,” it is a quantitative cap-and-floor.
  • Coating level “0.5% to 20%” ties directly to formulation composition.

3) Outer hard coating: drives the predominant flavor perceived

There is an outer hard coating on top of the inner polymer coating. Claim 1 requires:

  • The outer hard coating exists as a physical layer.
  • The flavor perceived during chewing is predominantly the “second” flavoring agent (from the inner polymer layer), not the “first” flavoring agent in the core.

Claim scope notes

  • “Outer hard coating” is structural, but not chemically specified in Claim 1.
  • The “predominantly” flavor outcome is a functional limitation. In practice, this can be supported by sensory testing, but for infringement it can be argued based on release/viscosity behavior. The claim ties flavor dominance to coating layering.

How do the dependent claims narrow Claim 1?

Claim 2: Plasticizer presence in the inner polymer coating

  • Inner polymer coating further comprises a plasticizer.

Claim 3: Plasticizer is polysorbate

  • Plasticizer is specifically polysorbate.

Scope effect

  • Polysorbate inclusion narrows the compliant inner coating formulation if Claim 3 is asserted.

Claim 4: Inner and outer coatings are devoid of any active pharmaceutical ingredient

  • Inner and outer coatings contain no active pharmaceutical ingredient.

Scope effect

  • This limits actives beyond nicotine to the core.
  • It also excludes adding other actives (for example fluoride sources if treated as actives rather than excipients) into the coatings, depending on claim construction.

Claim 5: Outer hard coating sweetening agent list

Outer hard coating must contain at least one sweetening agent selected from:

  • monosaccharides
  • disaccharides
  • polysaccharides
  • sugar alcohols
  • soluble saccharin salts
  • aspartame
  • neotame
  • chlorinated derivatives of sucrose
  • chlorinated derivatives of sucralose
  • thaumatoccous danielli
  • mixtures

Scope effect

  • This is a defined ingredient class. It does not limit other excipients in the outer coating, but the sweetener must be within the listed group if Claim 5 is used.

Claim 6: Inner polymer film coating additives list

Inner polymer coating can further comprise one or more ingredients selected from:

  • fluoride ion sources
  • tooth desensitizing agents
  • enzymes
  • antioxidants
  • pH adjusting agents
  • mixtures

Scope effect

  • Claim 6 expands functional versatility of the inner coating while staying within the coating layer concept.
  • It interacts with Claim 4’s “devoid of any active pharmaceutical ingredient” in a way that can become a claim construction hinge: fluoride ion sources can be treated as dental actives. The claim set does not specify whether those are excluded by Claim 4 or allowed because Claim 4 excludes “active pharmaceutical ingredient” rather than any “active” category.

Claim 7: Inner polymer film coating includes cinnamic aldehydes of cinnamon flavor

  • Inner polymer coating includes cinnamic aldehydes of cinnamon flavor.

Scope effect

  • This pins a specific flavor chemical motif within the second flavor system.

Claim 8: Flavor pairing for core and inner coating

  • Core first flavoring agent = mint
  • Inner polymer coating second flavoring agent = selected from:
    • citrus
    • cinnamon
    • berry
    • mixed fruit

Scope effect

  • Claim 8 enforces a specific flavor pairing strategy consistent with “predominantly second flavor” perception.

What is the independent claim’s literal claim boundaries? (Practical infringement checklist)

A product must match the following combination to fall within the core of Claim 1:

Element Required limitation in Claim 1 What a design-around would target
Core nicotine Chewing gum base + nicotine in any form Remove nicotine from gum core or change delivery (non-gum route)
Core flavor/sweetener/pH First flavor + first sweetener + at least one pH regulating agent Omit pH regulation (but this can break nicotine stability and is likely non-trivial)
Inner coating polymer HPMC or HPC (or mixtures) Use a different polymer film-former
Inner coating flavor loading Second flavor is 30% to 50% by weight of inner polymer coating Change loading outside 30-50% or change “second flavor” identity
Inner coating sweetener Second sweetener present Eliminate or relocate sweetener logic
Inner coating quantity Inner polymer coating about 0.5% to 20% by weight of core Use amount outside this band
Outer coating Outer hard coating on the inner polymer coating Remove hard coating layer or replace with non-hard/other architecture
Flavor outcome Predominantly flavor from second flavor system upon chewing Engineer release such that first flavor dominates or becomes comparable

Claims 2-8 add further narrowing only if a challenger asserts the dependent claim as well or if the claims are construed such that a narrower embodiment is required.


How is “scope” shaped by the flavor perception limitation?

Claim 1 includes a functional flavor outcome:

  • “the flavor perceived upon chewing of the chewing gum predominantly is the flavor provided by the … second flavoring agent.”

This creates two important scope mechanics:

1) Layering drives dominance, not just inclusion A competitor cannot simply place cinnamon/citrus in an inner layer. They must create conditions where that flavor is predominantly what consumers perceive while chewing.

2) Evidence can be composition- and process-dependent Predominance can depend on:

  • coat thickness and density
  • solubility and partitioning of the second flavor
  • plasticizer and matrix interactions
  • saliva interaction and chewing mechanics

For a freedom-to-operate posture, this means products with “mostly compliant” composition can still argue non-infringement if consumer perception (or objective flavor release profile) does not meet the “predominantly” requirement.


What does the patent cover beyond nicotine?

The claims tie nicotine delivery to a flavor-control coating strategy. But the dependent claims provide a route to include dental-oral care excipients in the inner coating:

  • fluoride ion sources
  • tooth desensitizing agents
  • enzymes
  • antioxidants
  • pH adjusting agents

The patent scope therefore extends to nicotine chewing gum that also includes oral care add-ins, at least where those additives are placed in the inner polymer coating and comply with the “no active pharmaceutical ingredient” constraint in Claim 4.


Patent landscape: how crowded is this design space in the US?

Without a full prosecution-history file wrapper and claim-set map to neighboring patents, the US landscape can still be characterized based on well-established product categories:

1) Nicotine gum patents commonly cover nicotine form, dosing, stability, and release

In general, nicotine gum art is thick around:

  • nicotine salt selection
  • pH regulation systems
  • gum base compositions
  • controlled release approaches

8,323,683 distinguishes itself by tying those to a specific two-layer coating and quantitative inner coating flavor loading plus polymer identity.

2) Flavor-release engineering for chewing gum is also heavily patented

Chewing gum flavor systems often use:

  • flavor in the gum base
  • encapsulation
  • coated particles
  • polymer films
  • hard coatings

8,323,683 narrows to:

  • an inner polymer film based on HPMC/HPC
  • a hard outer coating
  • a defined second flavor loading in the inner coating (30%-50% by weight of the inner polymer coating)
  • a “predominantly second flavor” outcome.

3) Oral-care additives (fluoride/desensitizers/enzymes) in confection and gum are common

Fluoride and enzyme-containing oral care compositions are widely claimed in oral dosage forms.

The unique part in 8,323,683 is their placement and relationship:

  • Claim 6 puts these optional ingredients into the inner polymer film coating.

Where are the strongest potential overlaps in infringement risk?

The claim set is most vulnerable to overlap from competitors who:

1) Use HPMC/HPC as film-formers in nicotine gum coatings
2) Load a “second” flavor system at 30% to 50% by weight of the inner coating
3) Apply a hard outer coating above the inner film
4) Use mint as core flavor and citrus/cinnamon/berry/mixed fruit as inner coating second flavor (if Claim 8 is asserted)
5) Include pH regulating agents in the core
6) Place additional actives/excipients into the inner coating consistent with Claim 6


Where are likely design-arounds that reduce overlap with Claim 1?

The most direct design-around levers are structural:

  • Replace HPMC/HPC with a different polymer film-former for the inner coating
  • Change the “second flavoring agent” loading so it is not 30% to 50% by weight of the inner coating
  • Alter the coating amount so inner polymer is not 0.5% to 20% of the core
  • Remove or replace the outer hard coating layer
  • Modify formulation and release so the flavor perceived is not “predominantly” the second flavor

These are the levers with the highest probability of avoiding literal infringement because each one breaks a specific numbered limitation in Claim 1.


Key takeaways

  • US 8,323,683 protects a nicotine gum with a core + HPMC/HPC inner polymer coating + hard outer coating architecture that drives the predominant flavor perception from the inner-layer second flavor.
  • The most defining, high-risk limitations are:
    • Inner coating polymer must be HPMC/HPC
    • Second flavor load in the inner coating is 30% to 50% by weight
    • Inner coating amount is 0.5% to 20% by weight of the core
    • Outer hard coating must be present to achieve predominance
  • Dependent claims add narrow formulation hooks: polysorbate plasticizer, specific outer sweetener classes, and optional fluoride/desensitizers/enzymes/antioxidants/pH adjusting agents in the inner coating, plus a specific mint + citrus/cinnamon/berry flavor pairing.

FAQs

1) Does the patent require nicotine in the inner or outer coatings?

No. Claim 1 requires nicotine in the core. Claim 4 further states the inner and outer coatings are devoid of any active pharmaceutical ingredient.

2) What polymers does the patent specifically allow for the inner coating?

HPMC (hydroxypropylmethyl cellulose) and/or HPC (hydroxypropyl cellulose).

3) Is the “second flavoring agent” quantity flexible?

No. Claim 1 fixes it at 30% to 50% by weight of the inner polymer coating.

4) What determines whether a product infringes the “predominantly” flavor feature?

It is a functional limitation tied to consumer-perceived flavor during chewing and the relationship between the inner and outer coating layers that control flavor release.

5) Which dependent claim adds polysorbate?

Claim 3: the inner polymer coating plasticizer is polysorbate.


References

[1] United States Patent 8,323,683.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 8,323,683

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Haleon Us Holdings NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 018612-002 Feb 9, 1996 OTC Yes No 8,323,683 ⤷  Start Trial ⤷  Start Trial
Haleon Us Holdings NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 020066-002 Feb 9, 1996 OTC Yes Yes 8,323,683 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,323,683

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 053731 ⤷  Start Trial
Australia 2006247847 ⤷  Start Trial
Brazil PI0611520 ⤷  Start Trial
Canada 2608531 ⤷  Start Trial
China 101222915 ⤷  Start Trial
China 103784423 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.